Wexner Medical Center Among the First in the Nation to Administer New Gene Therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis, a neurodegenerative disease that affects the cells in the brain and spine.